FDA Seeks Public Input On Psychedelic Research Involving Ibogaine

Marijuana Moment
By Tom AngellOct 5, 2026, 10:29 am138 ptsTrendingTop
The Food and Drug Administration (FDA) is seeking public input on how to design research on the potential therapeutic benefits of the psychedelic ibogaine. The agency’s request for information (RFI), released on Monday, seeks comments and data in four main areas: General study design, including appropriate…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

There Are ‘No Deaths From Overdose Of Marijuana,’ DEA Confirms In Updated Report 80

Roadwise Award Nominees: Cannabis Safety Awards 2026 79

Last Week in Weed: September 28-October 4, 2026 – New York Sales Grow as States Revisit Access 78

Washington Says 80% of Marijuana Licensees Use Third-Party Traceability Integrators the State Does Not License 72

Illinois Marijuana Retailers Sold to Minors in Just 6 of 1,452 State Compliance Checks 71

New York Sets November 5 Opening for Marijuana Nursery Licenses, With Applications Capped at 50 70

Georgia Regulators Approve Medical Cannabis Delivery Rules 65

Vanquish Medical Brings Craft Cannabis to Canadian Patients 56

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.